Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

The Identification of Chemical and Bacterial Composition and Determination of FimH Gene Frequency of Kidney Stones of Iranian Patients

Ali Shojaeian 1 , * , Mosayeb Rostamian 2 , Jamileh Noroozi 1 and Parviz Pakzad 1
Authors Information
1 Department of Microbiology, Faculty of Basic Sciences, Tehran North Branch, Islamic Azad University, Tehran, IR Iran
2 Department of Immunology, Pasteur Institute of Iran, Tehran, IR Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: June 30, 2016, 18 (6); e7363
  • Published Online: June 18, 2016
  • Article Type: Research Article
  • Received: January 26, 2015
  • Accepted: July 10, 2015
  • DOI: 10.17795/zjrms-7363

To Cite: Shojaeian A, Rostamian M, Noroozi J, Pakzad P. The Identification of Chemical and Bacterial Composition and Determination of FimH Gene Frequency of Kidney Stones of Iranian Patients, Zahedan J Res Med Sci. 2016 ; 18(6):e7363. doi: 10.17795/zjrms-7363.

Abstract
Copyright © 2016, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3.Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Yoshida O, Terai A, Ohkawa T, Okada Y. National trend of the incidence of urolithiasis in Japan from 1965 to 1995. Kidney Int. 1999; 56(5): 1899-904[DOI][PubMed]
  • 2. Verkoelen CF, van der Boom BG, Schroder FH, Romijn JC. Cell cultures and nephrolithiasis. World J Urol. 1997; 15(4): 229-35[PubMed]
  • 3. Mandel N. Mechanism of stone formation. Semin Nephrol. 1996; 16(5): 364-74[PubMed]
  • 4. Ma W, Guttman DS. Evolution of prokaryotic and eukaryotic virulence effectors. Curr Opin Plant Biol. 2008; 11(4): 412-9[DOI][PubMed]
  • 5. Oelschlaeger TA, Dobrindt U, Hacker J. Virulence factors of uropathogens. Curr Opin Urol. 2002; 12(1): 33-8[PubMed]
  • 6. Hommais F, Gouriou S, Amorin C, Bui H, Rahimy MC, Picard B, et al. The FimH A27V mutation is pathoadaptive for urovirulence in Escherichia coli B2 phylogenetic group isolates. Infect Immun. 2003; 71(6): 3619-22[PubMed]
  • 7. Connell H, Poulsen LK, Klemm P. Expression of type 1 and P fimbriae in situ and localisation of a uropathogenic Escherichia coli strain in the murine bladder and kidney. Int J Med Microbiol. 2000; 290(7): 587-97[DOI][PubMed]
  • 8. Schembri MA, Christiansen G, Klemm P. FimH-mediated autoaggregation of Escherichia coli. Mol Microbiol. 2001; 41(6): 1419-30[PubMed]
  • 9. Zanetti G, Paparella S, Trinchieri A, Prezioso D, Rocco F, Naber KG. Infections and urolithiasis: current clinical evidence in prophylaxis and antibiotic therapy. Arch Ital Urol Androl. 2008; 80(1): 5-12[PubMed]
  • 10. Qaader DS, Yousif SY, Mahdi LK. Prevalence and etiology of urinary stones in hospitalized patients in Baghdad. East Mediterr Health J. 2006; 12(6): 853-61[PubMed]
  • 11. Gomez-Nunez JC, Alvarez UM, Fernandez F. Infected urinary stones, endotoxins and urosepsis. 2011; : 183-98
  • 12. Fallah-Merhrabadi J, Ghoraba H, Imani Fooladi AA, Rohaninejad H. Comparing of fimH gene variation in normal flora and uropathogenic Escherichia coli. Trauma Mon. 2010; 15(2): 65-9
  • 13. Miano R, Germani S, Vespasiani G. Stones and urinary tract infections. Urol Int. 2007; 79 Suppl 1: 32-6[DOI][PubMed]
  • 14. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003; 63(5): 1817-23[DOI][PubMed]
  • 15. Rivera JV. Urinary calculi in Puerto Rico: II. Seasonal incidence. Bol Asoc Med P R. 1973; 65(2): 28-31[PubMed]
  • 16. Kramer G, Klingler HC, Steiner GE. Role of bacteria in the development of kidney stones. Curr Opin Urol. 2000; 10(1): 35-8[PubMed]
  • 17. Ansari MS, Gupta NP, Hemal AK, Dogra PN, Seth A, Aron M, et al. Spectrum of stone composition: structural analysis of 1050 upper urinary tract calculi from northern India. Int J Urol. 2005; 12(1): 12-6[DOI][PubMed]
  • 18. Akagashi K, Tanda H, Kato S, Ohnishi S, Nakajima H, Nanbu A, et al. Characteristics of patients with staghorn calculi in our experience. Int J Urol. 2004; 11(5): 276-81[DOI][PubMed]
  • 19. Griffith DP. Struvite stones. Kidney Int. 1978; 13(5): 372-82[PubMed]
  • 20. Parmar MS. Kidney stones. BMJ. 2004; 328(7453): 1420-4[DOI][PubMed]
  • 21. Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest. 2005; 115(10): 2598-608[DOI][PubMed]
  • 22. Tavichakorntrakool R, Prasongwattana V, Sungkeeree S, Saisud P, Sribenjalux P, Pimratana C, et al. Extensive characterizations of bacteria isolated from catheterized urine and stone matrices in patients with nephrolithiasis. Nephrol Dial Transplant. 2012; 27(11): 4125-30[DOI][PubMed]
  • 23. Pak CY. Etiology and treatment of urolithiasis. Am J Kidney Dis. 1991; 18(6): 624-37[PubMed]
  • 24. Abrahams HM, Stoller ML. Infection and urinary stones. Curr Opin Urol. 2003; 13(1): 63-7[DOI][PubMed]
  • 25. Grases F, March JG, Conte A, Costa-Bauza A. New aspects on the composition, structure and origin of calcium oxalate monohydrate calculi. Eur Urol. 1993; 24(3): 381-6[PubMed]
  • 26. Ciftcioglu N, Bjorklund M, Kuorikoski K, Bergstrom K, Kajander EO. Nanobacteria: an infectious cause for kidney stone formation. Kidney Int. 1999; 56(5): 1893-8[DOI][PubMed]
  • 27. Park S, Pearle MS. Pathophysiology and management of calcium stones. Urol Clin North Am. 2007; 34(3): 323-34[DOI][PubMed]
  • 28. Usein CR, Damian M, Tatu-Chitoiu D, Capusa C, Fagaras R, Tudorache D, et al. Prevalence of virulence genes in Escherichia coli strains isolated from Romanian adult urinary tract infection cases. J Cell Mol Med. 2001; 5(3): 303-10[PubMed]
  • 29. Kaczmarek A, Budzynska A, Gospodarek E. Prevalence of genes encoding virulence factors among Escherichia coli with K1 antigen and non-K1 E. coli strains. J Med Microbiol. 2012; 61: 1360-5[DOI][PubMed]
  • 30. Khorshidi A, Motallebi M, Rohani M, Piroozmand A. Characterization of virulence genes in typical and atypical enteropathogenic Escherichia coli. Sci Res Essays. 2011; 6(31): 6600-5
  • 31. Karimian A, Momtaz H, Madani M. Detection of uropathogenic Escherichia coli virulence factors in patients with urinary tract infections in Iran. Afri J Mic Res. 2012; 6(39): 6811-6
  • 32. Moreno E, Andreu A, Perez T, Sabate M, Johnson JR, Prats G. Relationship between Escherichia coli strains causing urinary tract infection in women and the dominant faecal flora of the same hosts. Epidemiol Infect. 2006; 134(5): 1015-23[DOI][PubMed]
  • 33. Lichodziejewska M, Topley N, Steadman R, Mackenzie RK, Jones KV, Williams JD. Variable expression of P fimbriae in Escherichia coli urinary tract infection. Lancet. 1989; 1(8652): 1414-8[PubMed]
  • 34. Pere A, Nowicki B, Saxen H, Siitonen A, Korhonen TK. Expression of P, type-1, and type-1C fimbriae of Escherichia coli in the urine of patients with acute urinary tract infection. J Infect Dis. 1987; 156(4): 567-74[PubMed]
  • 35. Kisielius PV, Schwan WR, Amundsen SK, Duncan JL, Schaeffer AJ. In vivo expression and variation of Escherichia coli type 1 and P pili in the urine of adults with acute urinary tract infections. Infect Immun. 1989; 57(6): 1656-62[PubMed]
  • 36. Brinton CJ. Non-flagellar appendages of bacteria. Nature. 1959; 183(4664): 782-6[PubMed]
  • 37. Ofek I, Goldhar J, Eshdat Y, Sharon N. The importance of mannose specific adhesins (lectins) in infections caused by Escherichia coli. Scand J Infect Dis Suppl. 1982; 33: 61-7[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments